dpp 4 inhibitors and glp 1 vs GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? The Role of GLP-1, DPP-4, – The Role of DPP-4 Inhibitors

D., Nau, M

Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis. EClinicalMedicine, 2025

Clinical trials indicate that participants with a BMI 30 kg/m or those with overweight and comorbid conditions such as type 2 diabetes or metabolic-associated fatty liver disease (MASLD) may experience the most pronounced benefits

Whether you are on insulin, a GLP-1, or both, regular HbA1c testing (typically every three months) remains the standard for assessing long-term glucose control

State-of-the-Art Facility : Our modern wellness center and medi-spa is equipped with the latest technology and amenities to provide you with a comfortable and effective treatment experience

doi: 10.1021/jacs.0c00561 147 YangJ